Skip to content

SCOVERNLAW

Superb Listening | Serious Lawyering

Toggle menu
  • About
  • Practice Areas
    • Defective Drugs
    • Defective Products
    • Toxic Exposure
    • Catastrophic Injury
  • News
  • Referrals
  • Contact Us

Category: Zyloprim and Allopurinol

March 1, 2021March 1, 2021Uncategorized, Zyloprim and Allopurinol

Blacks, Asians at Higher Risk for Allopurinol-Related Skin Reactions

By Deborah Levenson Be careful when prescribing allo¬purinol to black and Asian gout patients, a study newly advises. Black and Asian patients […]

November 30, 2020November 30, 2020Zyloprim and Allopurinol

FDA Uloric Warning Renews Concerns over Older Gout Drug Allopurinol

Terry Turner, Drugwatch The number of people taking the gout medication allopurinol has been rising as gout becomes more prevalent. Prescriptions also […]

September 21, 2020November 9, 2022Zyloprim and Allopurinol

Gout Flare Common Following Allopurinol Discontinuation

It is necessary to continue urate-lowering therapy in the inpatient setting to decrease the risk of gout flare in hospitalized patients.   […]

© 2025 SCOVERNLAW.
WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien